Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair.

IBM CEO Talks Confluent Acquisition and AI Impact
10:22

Strategas Research Partners CEO Talks Financial Services
12:36

US Interior Secretary Doug Burgum Talks US Energy Production
14:53